Fine Organic Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on May 08, 2025.
FINEORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Fine Organic Industries' board approved standalone and consolidated audited financial results for Q4 and FY ended March 31, 2025, with an unmodified (clean) audit opinion from B Y & Associates. Standalone revenue from operations rose to Rs. 2,205 crore from Rs. 1,951 crore (about 13% YoY), while net profit grew to Rs. 390 crore from Rs. 368 crore (about 6% YoY), translating to EPS of Rs. 127.09. The board recommended a final dividend of Rs. 11 per share (face value Rs. 5), with a record date of July 26, 2025 and AGM scheduled for August 21, 2025. The company also approved setting up wholly owned subsidiaries in the USA and UAE to expand its specialty chemicals footprint internationally. Additionally, M/s. CNK & Associates LLP was appointed as new statutory auditor and M/s. NKS & Co. as secretarial auditor, each for a 5-year term subject to shareholder approval at the upcoming AGM.
Steady topline growth, stable margins, and a clean audit opinion are positive signals for shareholders, while the dividend and overseas expansion plans reflect management's confidence. The planned statutory auditor rotation is a routine governance step and not a mid-year change, so it should not raise alarm. Investors should watch the USA and UAE subsidiaries for execution progress in coming quarters.